Table 2: Demographics and risk factors of patients who developed HDAVB versus no HDAVB after TAVI.

	HDAVB (n=3,480)	No HDAVB (n=30,210)	p-value
Age (mean ± standard deviation)	82 ± 8	81 ± 9	<0.001
Male	50.9%	50.6%	0.89
Race White	82.6%	81.2%	0.35
Hypertension	79.2%	79.5%	0.84
Diabetes	37.4%	34.2%	0.07
Dyslipidemia	62.8%	64.1%	0.49
Current smoking	2.7%	3.4%	0.31
Obesity	14.5%	14.8%	0.83
Coronary artery disease	30.2%	70.6%	0.69
Prior PCI	17.4%	18.4%	0.48
Prior CABG	18.7%	20.9%	0.15
Prior stroke/TIA	10.6%	9.9%	0.54
Anemia	25.3%	26.7%	0.40
Renal failure	39.4%	34.9%	0.02
Chronic pulmonary disease	32.5%	33.7%	0.54
Peripheral vascular disease	29.2%	30.0%	0.61
Atrial fibrillation	39.1%	43.7%	0.02
In-hospital mortality	5.5%	4.1%	0.07

CABG: coronary artery bypass grafting, PCI: percutaneous coronary intervention, TAVI: trans-catheter aortic valve implantation, TIA: transient ischemic attack,